Practical Applications of New Agents in Oncology is a nationally recognized conference for health care professionals designed to give them information on results of clinical studies of new anticancer agents and current treatment strategies. National experts presenting at this conference will be addressing these needs and sharing their knowledge and expert opinion. In addition, attendees will gain the knowledge of how to use pharmacogenomics and personalized medicine approaches to help in the selection of novel new therapies for patients.
The conference will give an up-to-date review of recently approved new agents and promising investigational agents in oncology and hematology, and will provide educational opportunities for hematology/oncology fellows, nurse practitioners, physician assistants, Registered nurses, pharmacists, and clinical research coordinators.Topics will include approved novel targeted therapies and immune checkpoint therapies and those likely to be approved, underlying molecular mechanisms for new drug development, drug development pipelines, the transition from drug development in biopharmaceuticals, clinical trials, palliative care, survivorship and strategies to manage cancer patients during the ongoing COVID-19 pandemic. It is a continuing education (CME) activity designed for health care professionals specializing in oncology and hematology.
The Office of Continuing Medical Education in the Joe R. and Teresa Lozano Long School of Medicine and the UTHSA Department of Lifelong Learning Accredited Provider Unit (APU) reviewed all financial disclosure information for all speakers, facilitators, and planning committee members; and determined and resolved all conflicts of interests.
Course Director, Dr. Daruka Mahadevan
Please click here to view the 2021 Financial Disclosures.
Program
Continuing Education
You must attend the live conference during February 5-6, 2021 to claim continuing education credits. CE credits will not be given for watching the sessions On Demand.
CME
The UT Health San Antonio Joe R. & Teresa Lozano Long School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Successful completion of this CME activity, which includes participation in the polling and evaluation components, enables the participant to earn up to 15.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
CNE
University of Texas Health Science Center at San Antonio is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 14.42 contact hours will be awarded to registered nurses for attending the entire conference. Contact hours are awarded based on attendance and completion of the
evaluation through
a process associated with the conference. Please be sure that you provide
accurate credentials and an email address when registering. Nurses do not
have to submit to the TX Board of Nursing for the contact hours.
Complete the Conference Evaluation to claim ABIM Maintenance of Certificate (MOC)
points or Continuing Nursing Credits. All registered attendees were sent the evaluation by email on February 8.
CPE
The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is eligible for 10 hours of ACPE credit.
The
University of Texas at Austin College of Pharmacy will contact registered pharmacy attendees with instructions on how to claim your ACPE credit.
Meet The Speakers
Tom Aloia, MD, MHCM, FACS
The University of Texas
MD Anderson Cancer Center
Yesid Alvarado, MD
The University of Texas
MD Anderson Cancer Center
Sukeshi Arora, MD
UT Health San Antonio
MD Anderson Cancer Center
Matthew Butler , MD
UT Health San Antonio MD Anderson Cancer Center
Sherri Cervantez, MD
UT Health San Antonio
MD Anderson Cancer Center
Laura Chow, MD, FRCPC
The University of Texas at
Austin Dell Medical School
Michael Davies, MD, PhD
The University of Texas
MD Anderson Cancer Center
James Fletcher, MD, DPM, FACP, FASN, FAAHPM
University of Arkansas for Medical Sciences
Christopher Flowers, MD
The University of Texas MD Anderson Cancer Center
Jonathan Gelfond, MD, PhD
UT Health San Antonio
MD Anderson Cancer Center
Marina George, MD, MBA
The University of Texas MD Anderson Cancer Center
Yvonne Heung, MD, MS
The University of Texas MD Anderson Cancer Center
Kevin Kelly, MD
University of Southern
California
William Kelly, MD
UT Health San Antonio MD Anderson Cancer Center
Kate Lathrop, MD
UT Health San Antonio
MD Anderson Cancer Center
Georgia McCann, MD
UT Health San Antonio
MD Anderson Cancer Center
Funda Meric-Bernstam, MD
The University of Texas
MD Anderson Cancer Center
Jose Pacheco, MD
University of Colorado Anschutz Cancer Center
Chethan Ramamurthy, MD
UT Health San Antonio
MD Anderson Cancer Center
Adriana Rivera, PharmD
The University of Texas
MD Anderson Cancer Center
Britni Secor, PharmD
UT Health San Antonio
MD Anderson Cancer Center
Dimpy Shah, MD, PhD
UT Health San Antonio MD Anderson Cancer Center
Sunil Sharma, MD, FACP
Translational Genomics
Research Institute (Tgen)
Carol Stalzer, BSN, RN, CBCN
The University of Texas
MD Anderson Cancer Center
Vivek Subbiah, MD
The University of Texas
MD Anderson Cancer Center
Robert Svatek, MD
UT Health San Antonio MD Anderson Cancer Center
Christopher Takimoto, MD, PhD
Gilead Sciences
Jeremy Viles, DNP, MBA, RN, NE-BC
UT Health San Antonio
MD Anderson Cancer Center
Jim Welsh, MD
The University of Texas
MD Anderson Cancer Center
Support & Exhibits
Educational Grants
Support for general educational programming costs or specific items, or printed materials which are components of the educational program. The symposia office uses grant funds to defray expenses associated with educational activities in compliance with ACCME guidelines. If your company or organization offers educational grants in support of CME accredited educational activities related to clinical studies of new anticancer agents and current treatment strategies, we would appreciate receiving the grant application information. Please contact Sharon Hill, Director, Symposia at hills@uthscsa.edu or 210-450-1550.
This activity is supported by education grants provided by AstraZeneca, Exelixis, Novartis & Pfizer.
Support
We welcome any amount of support for this meeting which will be used to defray operating costs to support the 2021 Practical Applications of New Agents in Oncology conference. Please view the sponsorship options below:
Mobile App Landing Page and Banner Ad: $500- one available
The mobile app has over 150 users that will view your corporate brand ad on the landing page and banner ad. When the banner ad on the dashboard is tapped it will go to a URL site of your choice. Your company will be acknowledged on the 2021 Practical Applications of New Agents in Oncology website.
Mobile App Banner Ad: $250
The mobile app has over 150 users that will view your corporate brand ad on the banner ad. When the banner ad on the dashboard is tapped it will go to a URL site of your choice. Your company will be acknowledged on the 2021 Practical Applications of New Agents in Oncology website. One per sponsor.
OnAIR Banner Ad: $250- five available
The OnAIR platform will be used by all attendees to access the 2021 Virtual Practical Applications of New Agents in Oncology conference. The OnAIR Banner Ad will contain up to five rotating ads at the top of the OnAIR time. When the banner ad on the dashboard is tapped it will go to a URL site of your choice. Your company will be acknowledged on the 2021 Virtual Practical Applications of New Agents in Oncology website. Each image is sized at 870px by 155px. One per sponsor.
Login Page Sponsor: $500- one available
The OnAIR platform will be used by all attendees to access the 2021 Virtual Practical Applications of New Agents in Oncology conference. Company’s brand or product logo on the OnAIR login page. Your company will be acknowledged on the 2021 Virtual Practical Applications of New Agents in Oncology website.
Exhibits
The Symposia office uses exhibit fees to defray non-educational operating expenses.
Virtual exhibit: $1,500
Includes:
- Two complimentary registrations
- Lead Management
- Meeting Matching
Connect With Us
UT Health San Antonio MD Anderson Cancer Center
7979 Wurzbach Road, MC 8224
San Antonio, TX 78229
P: (210) 450-1550
Email: panao@uthscsa.edu
WE MAKE LIVES BETTER®
We are part of the UT Health San Antonio, provider of comprehensive health, dental & cancer care, advanced academics and life-saving research.